Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@]1([H])CCCC2)C(O)=O
InChI
InChIKey=IPVQLZZIHOAWMC-GVRJEKJASA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13-,14-,15+,16-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(±)-7A-epi-Perindopril is a mixture of two isomers (S, SR, SS) and (R, RS, RR) each of which is an isomer of the antihypertensive drug perindopril. The first of which has the same activity as the parent compound while the second one is almost inactive.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
dog: 1 mg/kg
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
145513-30-0
Created by
admin on Sat Dec 16 08:30:44 GMT 2023 , Edited by admin on Sat Dec 16 08:30:44 GMT 2023
|
PRIMARY | |||
|
R99KV37CY8
Created by
admin on Sat Dec 16 08:30:44 GMT 2023 , Edited by admin on Sat Dec 16 08:30:44 GMT 2023
|
PRIMARY | |||
|
72941688
Created by
admin on Sat Dec 16 08:30:44 GMT 2023 , Edited by admin on Sat Dec 16 08:30:44 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD